SCN9A and lung carcinoma: On the other hand, a study performed in NSCLC reported that the functional expression of SCN9A (Nav1.7) is controlled by EGF/EGFR signaling through the ERK1/2 pathway, which in turn promotes the invasion of H460 lung cancer cells.